Understanding and Optimizing Health-related Quality of Life and Physical Functional Capacity in Idiopathic Pulmonary Fibrosis

Overview

Journal Patient Relat Outcome Meas

Specialty Health Services

Date 2016 Jun 9

PMID 27274328

Citations 20

Authors

Amy L Olson

Kevin K Brown

Jeffrey J Swigris

Affiliations

Soon will be listed here.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive pulmonary disease characterized by the insidious onset of shortness of breath due to parenchymal scarring. As IPF progresses, breathlessness worsens, physical functional capacity declines, and health-related quality of life (HRQL) - the impact of health or disease on a person's satisfaction with their overall station in life - deteriorates. These two inextricably linked variables - breathlessness and physical functional capacity - are strong drivers of HRQL. With the emergence of new and prospective therapies for IPF, it is more important than ever to be able to accurately and reliably assess how IPF patients feel and function. Doing so will promote the development of novel interventions to target impairments in these areas and ensure that the field is capable of assessing the effect of therapeutics interventions on these critically important patient-centered outcomes.

Citing Articles

Effect of breathing exercises on patients with interstitial lung disease: A systematic review and meta-analysis.

Fan J, Chang Y, Cheng S, Liang B, Qu D Qual Life Res. 2024; 33(9):2335-2347.

PMID: 38907831 DOI: 10.1007/s11136-024-03679-z.

Effect of Home-Based Pulmonary Rehabilitation on Pulmonary Fibrosis.

Saha R, Singh V, Samuel S, Acharya K V, Acharya P, Kumar K Multidiscip Respir Med. 2024; 19.

PMID: 38836339 PMC: 11186438. DOI: 10.5826/mrm.2024.950.

Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.

Shao C, Xia N, Zhen Y, Zhang X, Yan N, Guo Q Front Immunol. 2024; 15:1404828.

PMID: 38745647 PMC: 11091831. DOI: 10.3389/fimmu.2024.1404828.

Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review.

Gupta R, Koteci A, Morgan A, George P, Quint J BMJ Open Respir Res. 2023; 10(1).

PMID: 37308252 PMC: 10277538. DOI: 10.1136/bmjresp-2022-001291.

Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.

Kreuter M, Hoffmann-Vold A, Matucci-Cerinic M, Saketkoo L, Highland K, Wilson H Rheumatology (Oxford). 2022; 62(SI):SI43-SI53.

PMID: 35640959 PMC: 9910566. DOI: 10.1093/rheumatology/keac325.

References

Guyatt G, Feeny D, Patrick D . Measuring health-related quality of life. Ann Intern Med. 1993; 118(8):622-9. DOI: 10.7326/0003-4819-118-8-199304150-00009. View

Patel A, Siegert R, Keir G, Bajwah S, Barker R, Maher T . The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med. 2013; 107(9):1438-43. DOI: 10.1016/j.rmed.2013.06.009. View

de Vries J, Seebregts A, Drent M . Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?. Respir Med. 2000; 94(3):273-8. DOI: 10.1053/rmed.1999.0736. View

Olson A, Swigris J, Belkin A, Hannen L, Yagihashi K, Schenkman M . Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance test. Expert Rev Respir Med. 2015; 9(3):361-7. DOI: 10.1586/17476348.2015.1030396. View

Nakayama M, Bando M, Araki K, Sekine T, Kurosaki F, Sawata T . Physical activity in patients with idiopathic pulmonary fibrosis. Respirology. 2015; 20(4):640-6. DOI: 10.1111/resp.12500. View

Hearty T, Schenkman M, Kohrt W, Cress M . Continuous scale physical functional performance test: appropriateness for middle-aged adults with and without Parkinson's disease. J Neurol Phys Ther. 2007; 31(2):64-70. DOI: 10.1097/NPT.0b013e3180676afa. View

Belkin A, Swigris J . Health-related quality of life in idiopathic pulmonary fibrosis: where are we now?. Curr Opin Pulm Med. 2013; 19(5):474-9. DOI: 10.1097/MCP.0b013e328363f479. View

King Jr T, Bradford W, Castro-Bernardini S, Fagan E, Glaspole I, Glassberg M . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2083-92. DOI: 10.1056/NEJMoa1402582. View

Elpern E, Stevens D, Kesten S . Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest. 2000; 118(1):98-105. DOI: 10.1378/chest.118.1.98. View

10.

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

11.

Gary R, Cress M, Higgins M, Smith A, Dunbar S . A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study. J Cardiovasc Nurs. 2011; 27(5):418-30. PMC: 4143391. DOI: 10.1097/JCN.0b013e31822ad3c3. View

12.

Kozu R, Senjyu H, Jenkins S, Mukae H, Sakamoto N, Kohno S . Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration. 2010; 81(3):196-205. DOI: 10.1159/000315475. View

13.

Waschki B, Kirsten A, Holz O, Muller K, Meyer T, Watz H . Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011; 140(2):331-342. DOI: 10.1378/chest.10-2521. View

14.

Fell C, Liu L, Motika C, Kazerooni E, Gross B, Travis W . The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008; 179(5):402-7. PMC: 2648909. DOI: 10.1164/rccm.200802-241OC. View

15.

Martinez T, Pereira C, Dos Santos M, Ciconelli R, Guimaraes S, Martinez J . Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000; 117(6):1627-32. DOI: 10.1378/chest.117.6.1627. View

16.

Ohno S, Nakazawa S, Kobayashi A, Bando M, Sugiyama Y . Reassessment of the classification of the severity in idiopathic pulmonary fibrosis using SF-36 questionnaire. Intern Med. 2005; 44(3):196-9. DOI: 10.2169/internalmedicine.44.196. View

17.

Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware Jr J . Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med. 1994; 149(2 Pt 1):371-5. DOI: 10.1164/ajrccm.149.2.8306032. View

18.

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View

19.

Ozalevli S, Karaali H, Ilgin D, Ucan E . Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2012; 5(1):31-7. PMC: 3463037. DOI: 10.1186/2049-6958-5-1-31. View

20.

Fried L, Ettinger W, Lind B, Newman A, GARDIN J . Physical disability in older adults: a physiological approach. Cardiovascular Health Study Research Group. J Clin Epidemiol. 1994; 47(7):747-60. DOI: 10.1016/0895-4356(94)90172-4. View